At a glance
- Originator Unknown
- Developer Nonindustrial source; Sankyo
- Class Antihypertensives
- Mechanism of Action Adenosine A2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypertension
Most Recent Events
- 17 Jul 1998 No-Development-Reported for Hypertension in Israel (PO)
- 17 Jul 1998 No-Development-Reported for Hypertension in Japan (PO)
- 25 Jul 1995 New profile